Source: Health Products Regulatory Authority (IE) Revision Year: 2019 Publisher: Unichem Laboratories Ltd, Studio 8B, Ard Gaoithe Commercial Centre, Ard Gaoithe Business Park, Cashel Road, Clonmel, Co Tipperary, Ireland
Bisocor 5 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. The tablets are pale yellow mottled in colour, round and convex with the following identification markings: BI centrally above a break-line with 5 below. The tablets can be divided into equal halves. |
Each tablet contains 5 mg of bisoprolol fumarate.
Excipient with known effect: Lactose Monohydrate 136 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Bisoprolol |
Bisoprolol is a potent highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and without relevant membrane stabilising activity. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Bisocor 5 mg tablets are presented in:
Blisters comprising of PVC/PVdC/aluminium foil, contained within a printed carton box. Each carton will contain either; 10, 20, 28, 30, 50, 56, 60, or 100 tablets.
Not all pack sizes may be marketed.
Unichem Laboratories Ltd, Studio 8B, Ard Gaoithe Commercial Centre, Ard Gaoithe Business Park, Cashel Road, Clonmel, Co Tipperary, Ireland
PA22654/003/001
Date of first authorisation: 29 June 2001
Date of last renewal: 05 September 2010
| Drug | Countries | |
|---|---|---|
| BISOCOR | Albania, Austria, Ireland, Singapore, Tunisia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
